TFF Pharmaceuticals(TFFP) - 2023 Q4 - Annual Results

Exhibit 99.1 TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results "Over the last several months, we have made significant progress showing that our Thin Film Freezing technology can be successfully applied, with both TFF TAC and TFF VORI demonstrating the potential to significantly improve the product profiles for two FDA- approved therapies," said Harlan Weisman, M.D., Chief Executive Officer of TFF Pharmaceuticals. "As recently announced, we made the decision to prioritize the c ...